BioLargo's subsidiary Clyra Medical secures over $1 million in direct investments to finalize the acquisition of the breakthrough stem cell therapy technology SkinDisc

Stock Information for Biolargo Inc

Loading

Please wait while we load your information from QuoteMedia.